Toronto, ON – Tm Bioscience says it has appointed Dr Donald Low as chairman of its scientific advisory board, effective immediately. With more than 30 years of experience, Dr Low is recognized world-wide as an authority in the area of emerging infectious diseases.
Dr Low is a professor of medicine and microbiology at the University of Toronto; head of the division of microbiology in the department of laboratory medicine and pathobiology at the University of Toronto; medical director of Public Health Laboratories; and chief of the Toronto Medical Laboratories and Mount Sinai Hospital department of microbiology. Among his many appointments, he is chair of the pandemic influenza planning executive committee at Mount Sinai Hospital.
“Developing products for infectious disease testing, one of the largest market opportunities for DNA based diagnostics, is a key focus of our company, says Greg Hines, president and CEO of Tm Bioscience. We welcome Dr. Low and anticipate that his expertise and guidance will prove invaluable as we advance our flagship infectious disease test through the regulatory clearance and commercialization processes.”